NAFDAC Caution Nigerians against Fake Augmentin Tablets in Circulation
The National Agency for Food and Drug Administration and Control (NAFDAC) has informed the public about the spread of fake Augmentin 625mg tablets in Nigeria. The FDA stated in a statement released on Friday that the alert was prompted by complaints from the legitimate maker of Augmentin, GlaxoSmithKline (GSK), regarding potential counterfeit versions of the drug in use. GSK verified that the product was fake after examining "documentary evidence, photographs, and a video from social media," according to NAFDAC.

